Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Acne vulgaris | Acne vulgaris | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Amikacin | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Antibiotic toolkit TARGET | Antimicrobial stewardship | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Azithromycin in adults with COPD | Azithromycin in adults with COPD - prophylactic | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Aztreonam lysine | Cystic fibrosis chronic pseudomonas aeruginosa (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Bezlotoxumab | Clostridium difficile | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Bictegravir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Blepharitis | Blepharitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bronchiectasis | Bronchiectasis - acute exacerbation of (non-cystic fibrosis) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Candidiasis | Candidiasis - oral | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Candidiasis | Candidiasis - vaginal | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Casirivimab plus imdevimab | COVID-19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cefiderocol | Drug-resistant gram-negative bacterial infections severe (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ceftazidime with avibactam | Drug-resistant gram-negative bacterial infections severe (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Cellulitis and erysipelas | Cellulitis and erysipelas | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Chlamydia trachomatis / urethritis | Chlamydia trachomatis / urethritis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Chronic Fatigue Syndrome/Myalgic Encephalitis (CFS & ME) Inpatient Treatment | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Clostridioides difficile infection | Clostridioides difficile infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cold sores | Cold sores | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Colistimethate sodium (Colobreathe) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Community LRTI Pneumonia Intravenous Antibiotic pathway for Housebound Care Home patients Pathway | n/a | Clinical pathways | East and North Hertfordshire | |
| COPD | COPD - acute exacerbation of | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Cough | Cough - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| COVID Virtual Ward | n/a | Patient information | East and North Hertfordshire | |
| COVID-19 Oximetry at Home | n/a | Patient information | East and North Hertfordshire | |
| COVID-19 Respiratory Disease Update | n/a | Patient information | Hertfordshire and West Essex ICB | |
| COVID-19 treatments: Information for clinicians | COVID-19 | n/a | Prescribing pathway | Hertfordshire and West Essex ICB |
| Darunavir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Dental abscess | Dental abscess | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dermatophyte infection | Dermatophyte infection: skin | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dermatophyte infection | Dermatophyte infection: nail | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diabetic foot infection | Diabetic foot infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diarrhoea | Diarrhoea infectious | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diarrhoea | Diarrhoea - Traveller’s | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Diverticulitis | Diverticulitis - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Dolutegravir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Eczema (bacterial infection) | Eczema (bacterial infection) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Efavirenz | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Elbasvir | Hepatitis C (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Emtricitabine | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Entecavir | Hepatitis B (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Epididymitis | Epididymitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Genital herpes | Genital herpes | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gingivitis | Gingivitis - simple - mucosal ulceration and inflammation | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gingivitis | Gingivitis - acute necrotising ulcerative | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Gonorrhoea | Gonorrhoea | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Grazoprevir | Hepatitis C (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Helicobacter pylori | Helicobacter pylori | Green | Decision document | Hertfordshire and West Essex ICB |
| Herpes zoster / shingles | Herpes zoster / shingles | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Human and animal bites | Human and animal bites | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Impetigo | Impetigo | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Infections in Primary Care | Infections | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Influenza | Influenza | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Insect bites and stings | Insect bites and stings | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Isavuconazole | Antifungal (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Lamivudine | Hepatitis B (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Leg ulcer infection | Leg ulcer infection | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Letermovir | Cytomegalovirus (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Linezolid | Antibacterial | Red | n/a | Hertfordshire and West Essex ICB |
| Mastitis | Mastitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Meningitis | Meningitis - prevention of secondary case | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Meningococcal disease | Meningococcal disease - suspected | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Minocycline | Acne | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
| Nevirapine | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Nirmatrelvir plus ritonavir | COVID-19 (CMDU only) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Nitazoxanide | Viral hepatitis (B&C) and respiratory syncytial virus (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Otitis externa | Otitis externa - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Otitis media | Otitis media - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Panton-Valentine leukocidin (PVL) | Panton-Valentine leukocidin (PVL) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Peginterferon and ropeginterferon | Hepatitis and Multiple sclerosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Pelvic inflammatory disease (PID) | Pelvic inflammatory disease (PID) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pericoronitis | Pericoronitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pneumonia | Pneumonia - community acquired | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pneumonia | Pneumonia - hospital acquired | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Posaconazole | Fungal infections (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Prostatitis | Prostatitis - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Pyelonephritis | Pyelonephritis - acute upper urinary tract | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Raltegravir | HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Remdesivir | COVID‑19 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Ritonavir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Scabies | Scabies | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Scarlet fever (GAS) | Scarlet fever (GAS) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Silver dressings | Wound Care | n/a | Position statement | Hertfordshire and West Essex ICB |
| Sinusitis | Sinusitis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sore throat | Sore throat - acute | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Sotrovimab | COVID-19 (CMDU only) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| STI screening | STI screening | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tenofovir | AIDS/ HIV Antiretroviral (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Threadworm | Threadworm | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tick bites (Lyme disease) | Tick bites (Lyme disease) | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tixagevimab plus cilgavimab | COVID‑19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tixagevimab plus cilgavimab | COVID-19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tobramycin (TOBI Podhaler) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tocilizumab | COVID-19 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Trichomoniasis | Trichomoniasis | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection | Urinary tract infection - lower | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection | Urinary tract infection - recurrent | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary tract infection | Urinary tract infection - catheter associated | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Urinary Tract Infections (UTI) | Recurrent - adult | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Vaginosis | Vaginosis - bacterial | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Varicella zoster / chickenpox | Varicella zoster / chickenpox | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Voriconazole | Chronic pulmonary aspergillosis and fungal infections (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |